Key Insights

Highlights

Treatment Research

1 treatments under study, led by Crofelemer

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2/3 (1)

Trial Status

Active Not Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT06721871Phase 2/3Active Not Recruiting

Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID)

Showing all 1 trials

Research Network

Common Treatments

  • Crofelemer1

Active Sponsors

  • Napo Pharmaceuticals, Inc.1

Top Investigators

Related Conditions

  • Rare Diseases1
  • Microvillus Inclusion Disease1
  • Congenital Disorders1

Activity Timeline